The goal of the revised quality metrics guidance is the collection of quality metrics data from life science companies to foster the FDA’s aim for risk-based inspection planning.

How does the FDA intend to use the quality metrics data?

What data are the FDA proposing is reported?

Download this webinar to learn what steps you need to take to prepare for the FDA Quality Metrics Program and our presenters will discuss:
  • How to understand the FDA’s Quality Metrics Vision

  • Learn How to Develop Enterprise-Wide Quality Metrics for Product Lifecycle

  •  The link to Lifecycle Process Validation

  • Consider Alternative Metrics

Presented by: 
Dr. Daniela Jansen, Dassault Systèmes BIOVIA
Dr. Carmen Medina, PAREXEL Consulting

Please complete this form to request this on-demand presentation »

Achieve a Competitive Edge Through Quality Metrics

Register to view: